ARIAD
is engaged in the discovery, development and commercialization of drugs for the patients with lung cancer... Read moreARIAD
is engaged in the discovery, development and commercialization of drugs for the patients with lung cancer... Read more
News
Apr 18, 2021
MedCity News
ARIAD: OrbiMed-incubated Theseus unveils $100M to beat cancer drug resistance
Oct 22, 2018
BioPortfolio
ARIAD: Ariad Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17092018 Prices from USD $250
Aug 19, 2018
BioPortfolio
ARIAD: Ariad Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 16042018 Prices from USD $250
Feb 28, 2018
BioPortfolio
ARIAD: Ariad Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15022018 Prices from USD $250
Dec 04, 2017
BioPortfolio
ARIAD: Ariad Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
Sep 07, 2017
BioPortfolio
ARIAD: ARIAD Pharmaceuticals Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Report Updated 14062017 Prices from USD $350
Jul 29, 2017
4-traders
ARIAD: Takeda Pharmaceutical : Boston-Area Defendant in SEC Insider Trading Case Faces Criminal Charges
Jul 24, 2017
BioPortfolio
ARIAD: Ariad Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile. Report Updated 20072017 Prices from USD $250
Jul 20, 2017
Blackbird
Press Release: ARIAD : Global Leukemia Therapeutics Market to Reach $2.6 Billion by 2025 - Analysis By Leukemia Type, Diagnosis, Treatment, Drugs, Route of Administration & Geography - Research and Markets
Jul 19, 2017
Reuters
ARIAD: Ex-Ariad employee's husband charged in U.S. with insider trading
ARIAD Competitors
1
2
3
4
5
6
7